Personalis at Biomarkers & Immuno-Oncology World Congress 2018:

June 11-13, 2018

Christelle Johnson, PhD
Senior Field Applications Scientist, Cancer Genomics & Immuno-Oncology
Personalis, Inc.

Tumor Immunogenomic Profiling: High-Content Assays and Analytics

Few platforms support multidimensional biomarker analysis. This talk will highlight ACE ImmunoID™ as a universal platform for biomarker discovery that enables comprehensive variant detection, neoantigen identification, and characterization of tumor immunogenomics. We will feature a case study demonstrating the platform’s ability to identify tumor escape mechanisms for cancer immunotherapy.